It is likely that these myeloid cells and blood borne biomarkers of pancreatic cancer act in symphony to induce some of the observed local changes in the MBH, which is confirmed by the high level of co-regulation between a number of these transcripts (e.g. lrg1, Plin4, Lcn2 and Icam1). The gene discussed is ICAM1; the disease is familial pancreatic carcinoma.